Comment on "High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa"

被引：2

作者：

Adelman, Madeline ^{[1
]}

Lyons, Alexis B. ^{[2
]}

Hamzavi, Iltefat H. ^{[2
]}

机构：

[1] Wayne State Univ, Sch Med, Detroit, MI USA

[2] Henry Ford Hosp, Dept Dermatol, Detroit, MI 48202 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 84卷 / 04期

关键词：

INFUSION REACTIONS;

D O I：

10.1016/j.jaad.2020.10.095

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：E201 / E202

页数：2

共 5 条

[1] The incidence and management of infusion reactions to infliximab: A large center experience [J].

Cheifetz, A ;

Smedley, M ;

Martin, S ;

Reiter, M ;

Leone, G ;

Mayer, L ;

Plevy, S .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (06) :1315-1324

[2] High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa [J].

Ghias, Mondana H. ;

Johnston, Andrew D. ;

Kutner, Allison J. ;

Micheletti, Robert G. ;

Hosgood, H. Dean ;

Cohen, Steven R. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (05) :1094-1101

[3]

Keshavarzian Ali, 2007, Gastroenterol Hepatol (N Y), V3, P381

[4] Infliximab-Related Infusion Reactions: Systematic Review [J].

Lichtenstein, Lev ;

Ron, Yulia ;

Kivity, Shmuel ;

Ben-Horin, Shomron ;

Israeli, Eran ;

Fraser, Gerald M. ;

Dotan, Iris ;

Chowers, Yehuda ;

Confino-Cohen, Ronit ;

Weiss, Batia .

JOURNAL OF CROHNS & COLITIS, 2015, 9 (09) :806-815

[5] Systematic review of immunomodulatory therapies for hidradenitis suppurativa [J].

Lim, Shi Yu Derek ;

Oon, Hazel H. .

BIOLOGICS-TARGETS & THERAPY, 2019, 13 :53-78

← 1 →